PYY
Selected indexed studies
- PYY, a Therapeutic Option for Type 2 Diabetes? (Clin Med Insights Endocrinol Diabetes, 2020) [PMID:32030069]
- PYY and the pancreas: inhibition of tumor growth and inflammation. (Peptides, 2007) [PMID:17194501]
- Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes. (Curr Opin Endocrinol Diabetes Obes, 2021) [PMID:33395088]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- PYY, a Therapeutic Option for Type 2 Diabetes? (2020) pubmed
- PYY and the pancreas: inhibition of tumor growth and inflammation. (2007) pubmed
- Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes. (2021) pubmed
- GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior. (2022) pubmed
- The role of PYY in feeding regulation. (2008) pubmed
- Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). (2020) pubmed
- The role of PYY in improving insulin resistance. (2026) pubmed
- PYY is a negative regulator of bone mass and strength. (2019) pubmed
- PYY (3-36) protects against high fat feeding induced changes of pancreatic islet and intestinal hormone content and morphometry. (2023) pubmed
- Hormone PYY does not Explain the Variability in Weight Loss After Roux-en-Y Gastric Bypass: Evidence From a Meta-Analysis. (2026) pubmed